Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - AERIE PHARMACEUTICALS INC | Financial_Report.xls |
EX-31.1 - EX-31.1 - AERIE PHARMACEUTICALS INC | d718257dex311.htm |
EX-31.2 - EX-31.2 - AERIE PHARMACEUTICALS INC | d718257dex312.htm |
EX-32.1 - EX-32.1 - AERIE PHARMACEUTICALS INC | d718257dex321.htm |
10-Q - 10-Q - AERIE PHARMACEUTICALS INC | d718257d10q.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the filing of the Quarterly Report on Form 10-Q of Aerie Pharmaceuticals, Inc., a Delaware corporation (the Company), for the period ended March 31, 2014 (the Report), the undersigned, Richard J. Rubino, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: May 13, 2014 | /s/ RICHARD J. RUBINO | |
Richard J. Rubino | ||
Chief Financial Officer (Principal Financial and Accounting Officer) |